-+ 0.00%
-+ 0.00%
-+ 0.00%

UBS Maintains Neutral on Qiagen, Lowers Price Target to $47

Benzinga·09/09/2026 18:14:25
Listen to the news
UBS analyst Dan Leonard maintains Qiagen (NYSE:QGEN) with a Neutral and lowers the price target from $52 to $47.